Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN14381346Phase 3Recruiting
Phase 3, randomised, double-blind trial in epilepsy comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Time to at least one seizure at 12 months post-surgery. Started Jul 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN14381346.